{"text": "<extra_id_0> LMP1 <extra_id_2> Protein <extra_id_1> Promotes Tumor Growth and Survival through Activation of <extra_id_0> Akt <extra_id_2> Protein <extra_id_1> , NFkappaB , and <extra_id_0> Stat3 <extra_id_2> Protein <extra_id_1> Pathways", "event": "<extra_id_0> <extra_id_1>"}
{"text": "To explore which pathways were required for the enhanced growth and survival of <extra_id_0> LMP1 <extra_id_2> Protein <extra_id_1> - induced lymphomas , splenocytes from wild-type and <extra_id_0> LMP1 <extra_id_2> Protein <extra_id_1> transgenic mice were cultured in the presence of inhibitors for <extra_id_0> Akt <extra_id_2> Protein <extra_id_1> , NFkappaB , <extra_id_0> Stat3 <extra_id_2> Protein <extra_id_1> , <extra_id_0> mTOR <extra_id_2> Protein <extra_id_1> , or MAPK and assayed for growth and survival by the MTS assay .", "event": "<extra_id_0> <extra_id_0> Negative_regulation inhibitors <extra_id_1> <extra_id_0> Theme Akt <extra_id_1> <extra_id_0> Negative_regulation inhibitors <extra_id_1> <extra_id_0> Theme Stat3 <extra_id_1> <extra_id_0> Negative_regulation inhibitors <extra_id_1> <extra_id_0> Theme mTOR <extra_id_1> <extra_id_1>"}
{"text": "As previously shown , wild-type lymphocytes were not viable in culture and could not be tested with the inhibitors .", "event": "<extra_id_0> <extra_id_1>"}
{"text": "However , the enhanced viability of <extra_id_0> LMP1 <extra_id_2> Protein <extra_id_1> transgenic lymphocytes was effectively blocked by treatment with triciribine , BAY11-7085 , cucurbitacin I , and slightly with SB203580 , but not by treatment with rapamycin , U0126 , or AG490 ( Figure 7 ) .", "event": "<extra_id_0> <extra_id_1>"}
{"text": "Triciribine inhibits the activation of <extra_id_0> Akt <extra_id_2> Protein <extra_id_1> and at 20 muM has been shown to induce growth arrest in cancer cells with aberrant <extra_id_0> Akt <extra_id_2> Protein <extra_id_1> activity [ 46 ] .", "event": "<extra_id_0> <extra_id_0> Negative_regulation inhibits <extra_id_1> <extra_id_0> Theme activation <extra_id_1> <extra_id_0> Positive_regulation activation <extra_id_1> <extra_id_0> Theme Akt <extra_id_1> <extra_id_1>"}
{"text": "The effects of triciribine on cell growth of the transgenic lymphocytes and lymphomas were apparent as low as 1 muM , suggesting that activation of <extra_id_0> Akt <extra_id_2> Protein <extra_id_1> is required for the survival and growth of <extra_id_0> LMP1 <extra_id_2> Protein <extra_id_1> transgenic lymphocytes and lymphoma cells ( Figure 7 ) .", "event": "<extra_id_0> <extra_id_0> Positive_regulation activation <extra_id_1> <extra_id_0> Theme Akt <extra_id_1> <extra_id_1>"}
{"text": "The effects of the inhibitors were assessed by identifying phosphorylated <extra_id_0> Akt <extra_id_2> Protein <extra_id_1> , <extra_id_0> Stat3 <extra_id_2> Protein <extra_id_1> , and total levels of <extra_id_0> IkappaBalpha <extra_id_2> Protein <extra_id_1> ( Figure 8 ) .", "event": "<extra_id_0> <extra_id_0> Phosphorylation phosphorylated <extra_id_1> <extra_id_0> Theme Akt <extra_id_1> <extra_id_0> Phosphorylation phosphorylated <extra_id_1> <extra_id_0> Theme Stat3 <extra_id_1> <extra_id_1>"}
{"text": "Treatment with triciribine effectively blocked phosphorylation of <extra_id_0> Akt <extra_id_2> Protein <extra_id_1> , and phosphorylated <extra_id_0> Akt <extra_id_2> Protein <extra_id_1> was no longer detected past 5 muM .", "event": "<extra_id_0> <extra_id_0> Negative_regulation blocked <extra_id_1> <extra_id_0> Theme phosphorylation <extra_id_1> <extra_id_0> Phosphorylation phosphorylation <extra_id_1> <extra_id_0> Theme Akt <extra_id_1> <extra_id_0> Phosphorylation phosphorylated <extra_id_1> <extra_id_0> Theme Akt <extra_id_1> <extra_id_0> Positive_regulation detected <extra_id_1> <extra_id_0> Theme phosphorylated <extra_id_1> <extra_id_1>"}
{"text": "Phosphorylated <extra_id_0> Stat3 <extra_id_2> Protein <extra_id_1> and <extra_id_0> IkappaBalpha <extra_id_2> Protein <extra_id_1> were still present at 25 muM .", "event": "<extra_id_0> <extra_id_0> Phosphorylation Phosphorylated <extra_id_1> <extra_id_0> Theme IkappaBalpha <extra_id_1> <extra_id_0> Phosphorylation Phosphorylated <extra_id_1> <extra_id_0> Theme Stat3 <extra_id_1> <extra_id_1>"}
{"text": "These findings suggest that triciribine specifically targets <extra_id_0> Akt <extra_id_2> Protein <extra_id_1> and that <extra_id_0> Akt <extra_id_2> Protein <extra_id_1> activation is required for the enhanced viability of the transgenic lymphocytes and lymphoma cells .", "event": "<extra_id_0> <extra_id_0> Regulation targets <extra_id_1> <extra_id_0> Theme Akt <extra_id_1> <extra_id_0> Positive_regulation activation <extra_id_1> <extra_id_0> Theme Akt <extra_id_1> <extra_id_1>"}
{"text": "Inhibition of NFkappaB signaling rapidly induces cell death of EBV-transformed lymphocytes [ 17 , 18 ] .", "event": "<extra_id_0> <extra_id_1>"}
{"text": "BAY11-7085 , an inhibitor of NFkappaB signaling , also greatly decreased the viability of the <extra_id_0> LMP1 <extra_id_2> Protein <extra_id_1> transgenic lymphocytes and lymphoma cells at doses as low as 1 muM , and at 5 muM the cells were completely nonviable ( Figure 7 ) .", "event": "<extra_id_0> <extra_id_1>"}
{"text": "This is well within the reported IC50 of 10 muM .", "event": "<extra_id_0> <extra_id_1>"}
{"text": "Phosphorylated <extra_id_0> Akt <extra_id_2> Protein <extra_id_1> , <extra_id_0> Stat3 <extra_id_2> Protein <extra_id_1> , and total <extra_id_0> IkappaBalpha <extra_id_2> Protein <extra_id_1> were still present up to treatment with 15 muM and then were no longer detected ( Figure 8 ) .", "event": "<extra_id_0> <extra_id_0> Phosphorylation Phosphorylated <extra_id_1> <extra_id_0> Theme Akt <extra_id_1> <extra_id_0> Phosphorylation Phosphorylated <extra_id_1> <extra_id_0> Theme Stat3 <extra_id_1> <extra_id_0> Positive_regulation present <extra_id_1> <extra_id_0> Theme IkappaBalpha <extra_id_1> <extra_id_0> Positive_regulation present <extra_id_1> <extra_id_0> Theme Phosphorylated <extra_id_1> <extra_id_0> Positive_regulation present <extra_id_1> <extra_id_0> Theme Phosphorylated <extra_id_1> <extra_id_0> Positive_regulation detected <extra_id_1> <extra_id_0> Theme IkappaBalpha <extra_id_1> <extra_id_0> Positive_regulation detected <extra_id_1> <extra_id_0> Theme Phosphorylated <extra_id_1> <extra_id_0> Positive_regulation detected <extra_id_1> <extra_id_0> Theme Phosphorylated <extra_id_1> <extra_id_1>"}
{"text": "This finding suggests that inhibition of NFkappaB can induce cell death in <extra_id_0> LMP1 <extra_id_2> Protein <extra_id_1> transgenic lymphocytes and lymphoma cells without significant effects on activation of <extra_id_0> Akt <extra_id_2> Protein <extra_id_1> or <extra_id_0> Stat3 <extra_id_2> Protein <extra_id_1> .", "event": "<extra_id_0> <extra_id_0> Regulation effects <extra_id_1> <extra_id_0> Theme activation <extra_id_1> <extra_id_0> Regulation effects <extra_id_1> <extra_id_0> Theme activation <extra_id_1> <extra_id_0> Positive_regulation activation <extra_id_1> <extra_id_0> Theme Akt <extra_id_1> <extra_id_0> Positive_regulation activation <extra_id_1> <extra_id_0> Theme Stat3 <extra_id_1> <extra_id_1>"}
{"text": "Cucurbitacin I inhibits activation of <extra_id_0> Stat3 <extra_id_2> Protein <extra_id_1> by suppressing the activation of its kinase <extra_id_0> JAK2 <extra_id_2> Protein <extra_id_1> .", "event": "<extra_id_0> <extra_id_0> Negative_regulation inhibits <extra_id_1> <extra_id_0> Theme activation <extra_id_1> <extra_id_0> Positive_regulation activation <extra_id_1> <extra_id_0> Theme Stat3 <extra_id_1> <extra_id_1>"}
{"text": "It has been shown to selectively inhibit the growth of tumors with constitutively activated <extra_id_0> Stat3 <extra_id_2> Protein <extra_id_1> [ 47 ] .", "event": "<extra_id_0> <extra_id_0> Positive_regulation activated <extra_id_1> <extra_id_0> Theme Stat3 <extra_id_1> <extra_id_1>"}
{"text": "Similarly , <extra_id_0> LMP1 <extra_id_2> Protein <extra_id_1> transgenic lymphocytes and lymphoma cells were susceptible to cucurbitacin I treatment starting at 0.1 muM , a dose that corresponds closely to the reported IC50 of 500 nM ( Figure 7 ) [ 47 ] .", "event": "<extra_id_0> <extra_id_1>"}
{"text": "Phosphorylated <extra_id_0> Akt <extra_id_2> Protein <extra_id_1> , <extra_id_0> Stat3 <extra_id_2> Protein <extra_id_1> , and total <extra_id_0> IkappaBalpha <extra_id_2> Protein <extra_id_1> were not detectable past 1 muM and at higher doses all protein levels were greatly decreased , indicative of the total loss of viability ( Figure 8 ) .", "event": "<extra_id_0> <extra_id_0> Phosphorylation Phosphorylated <extra_id_1> <extra_id_0> Theme Akt <extra_id_1> <extra_id_0> Phosphorylation Phosphorylated <extra_id_1> <extra_id_0> Theme Stat3 <extra_id_1> <extra_id_0> Positive_regulation detectable <extra_id_1> <extra_id_0> Theme Akt <extra_id_1> <extra_id_0> Positive_regulation detectable <extra_id_1> <extra_id_0> Theme IkappaBalpha <extra_id_1> <extra_id_0> Positive_regulation detectable <extra_id_1> <extra_id_0> Theme Stat3 <extra_id_1> <extra_id_0> Negative_regulation decreased <extra_id_1> <extra_id_0> Theme Akt <extra_id_1> <extra_id_0> Negative_regulation decreased <extra_id_1> <extra_id_0> Theme IkappaBalpha <extra_id_1> <extra_id_0> Negative_regulation decreased <extra_id_1> <extra_id_0> Theme Stat3 <extra_id_1> <extra_id_1>"}
{"text": "A second reported inhibitor of <extra_id_0> Stat3 <extra_id_2> Protein <extra_id_1> , AG490 , had no effect on growth ( Figure 7 ) , but activation of <extra_id_0> Akt <extra_id_2> Protein <extra_id_1> , <extra_id_0> Stat3 <extra_id_2> Protein <extra_id_1> , or levels of <extra_id_0> IkappaBalpha <extra_id_2> Protein <extra_id_1> were also not affected ( Figure 8 ) .", "event": "<extra_id_0> <extra_id_0> Negative_regulation inhibitor <extra_id_1> <extra_id_0> Theme Stat3 <extra_id_1> <extra_id_0> Regulation affected <extra_id_1> <extra_id_0> Theme IkappaBalpha <extra_id_1> <extra_id_1>"}
{"text": "These findings suggest that inhibition of <extra_id_0> Stat3 <extra_id_2> Protein <extra_id_1> can induce cell death in <extra_id_0> LMP1 <extra_id_2> Protein <extra_id_1> transgenic lymphocytes and lymphoma cells , but <extra_id_0> Stat3 <extra_id_2> Protein <extra_id_1> inhibition also has considerable crossover effects on <extra_id_0> Akt <extra_id_2> Protein <extra_id_1> and NFkappaB signaling .", "event": "<extra_id_0> <extra_id_0> Negative_regulation inhibition <extra_id_1> <extra_id_0> Theme Stat3 <extra_id_1> <extra_id_0> Negative_regulation inhibition <extra_id_1> <extra_id_0> Theme Stat3 <extra_id_1> <extra_id_1>"}
{"text": "<extra_id_0> LMP1 <extra_id_2> Protein <extra_id_1> has also been shown to activate JNK and p38 MAPK pathways [ 13 , 48 ] , and <extra_id_0> LMP1 <extra_id_2> Protein <extra_id_1> transgenic lymphocytes were mildly susceptible to growth inhibition by SB202190 , an inhibitor of p38 MAPK , but not U0126 , an inhibitor of <extra_id_0> MEK1 <extra_id_2> Protein <extra_id_1> / <extra_id_0> 2 <extra_id_2> Protein <extra_id_1> activity .", "event": "<extra_id_0> <extra_id_0> Negative_regulation inhibitor <extra_id_1> <extra_id_0> Theme 2 <extra_id_1> <extra_id_0> Negative_regulation inhibitor <extra_id_1> <extra_id_0> Theme MEK1 <extra_id_1> <extra_id_1>"}
{"text": "However , effects of SB202190 were only apparent at high doses ( > 10 muM ) , much higher than the reported IC50 of 0.35 muM , suggesting that p38 MAPK does not significantly contribute to the enhanced viability in <extra_id_0> LMP1 <extra_id_2> Protein <extra_id_1> transgenic lymphocytes or lymphoma cells ( Figure 7 ) .", "event": "<extra_id_0> <extra_id_1>"}
{"text": "Interestingly , both wild-type and <extra_id_0> LMP1 <extra_id_2> Protein <extra_id_1> transgenic lymphomas were similarly susceptible to triciribine , BAY11-7085 , and cucurbitacin I treatments , but not SB202190 , AG490 , or U0126 treatment , suggesting that activation of <extra_id_0> Akt <extra_id_2> Protein <extra_id_1> , NFkappaB , and <extra_id_0> Stat3 <extra_id_2> Protein <extra_id_1> but not MAPK pathways are characteristics associated with malignant transformation ( Figure 7 ) .", "event": "<extra_id_0> <extra_id_1>"}
{"text": "rapamycin , an inhibitor of <extra_id_0> mTOR <extra_id_2> Protein <extra_id_1> , did not affect the viability of the transgenic lymphocytes or lymphoma cells , confirming that <extra_id_0> mTOR <extra_id_2> Protein <extra_id_1> is not targeted by <extra_id_0> Akt <extra_id_2> Protein <extra_id_1> activation in <extra_id_0> LMP1 <extra_id_2> Protein <extra_id_1> transgenic lymphocytes or malignant lymphoma cells ( Figure 7 ) .", "event": "<extra_id_0> <extra_id_0> Negative_regulation inhibitor <extra_id_1> <extra_id_0> Theme mTOR <extra_id_1> <extra_id_0> Regulation targeted <extra_id_1> <extra_id_0> Theme mTOR <extra_id_1> <extra_id_1>"}
